They’ve Got Next: The 40 Under 40 - Kristen Riemenschneider of Arnold & Porter

Please describe two of your most substantial, recent wins in practice.
I specialize in life sciences license and collaboration agreements. I have worked on many groundbreaking products, including two of the first approved gene therapies. In 2020, however, my work focused almost entirely on Covid-19 countermeasures, invoking my unique subspecialty advising on the IP rights associated with U.S. government-funded research and development. In the last year, I worked with more than two dozen companies as they sought U.S. government funding to support research, development and manufacturing scale-up, including two of the major Covid-19 vaccine manufacturers. I represented these companies in ...